Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,085,975 papers from all fields of science
Search
Sign In
Create Free Account
Fibrosis of bile duct
Known as:
FIBROSIS BILIARY
, biliary fibrosis
, biliary sclerosis
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Cholangitis, Sclerosing
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
Jessica W. Wen
,
Abby L. Olsen
,
M. Perepelyuk
,
R. Wells
Journal of Visualized Experiments
2012
Corpus ID: 37851404
Liver fibrosis is defined by the excessive deposition of extracellular matrix by activated myofibroblasts. There are multiple…
Expand
2005
2005
Hepatic arterial infusion of floxuridine and dexamethasone plus high‐dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma
N. Kemeny
,
Ahmed Abulfotooh Eid
,
+4 authors
P. Paty
Journal of Surgical Oncology
2005
Corpus ID: 30177966
In vitro data suggest increased cytotoxicity with Mitomycin C (Mit‐C) and Floxuridine (FUDR). Based on these data, we performed a…
Expand
2004
2004
Effects of Dexamethasone or Celecoxib on Biliary Toxicity after Hepatic Arterial Infusion of 5-Fluorodeoxyuridine in a Canine Model
W. Ensminger
,
J. Knol
,
+4 authors
J. Maybaum
Cancer Research
2004
Corpus ID: 14336690
Previous work has shown that in humans the dose-limiting toxicity for fluorodeoxyuridine [2-fluoro-5′-deoxyuridine (FdUrd)] when…
Expand
2001
2001
Irinotecan Hepatic Arterial Infusion Chemotherapy for Hepatic Metastases from Colorectal Cancer: Results of a Phase I Clinical Study
G. Fiorentini
,
Silvia Ricci Lucchi
,
P. Giovanis
,
M. Cantore
,
S. Guadagni
,
G. Papiani
Tumori
2001
Corpus ID: 19406884
Background Hepatic arterial infusion chemotherapy is a promising approach in liver metastases from colorectal cancer, but…
Expand
Review
2001
Review
2001
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities.
G. Fiorentini
,
D. Poddie
,
+6 authors
D. Turci
Hepato-Gastroenterology
2001
Corpus ID: 5814567
Liver metastasis of colorectal cancer is a life-threatening prognostic factor. Hepatic resection, when possible, is the best…
Expand
Review
2000
Review
2000
Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments
G. Fiorentini
,
D. Poddie
,
+8 authors
M. Marangolo
Medical Oncology
2000
Corpus ID: 23966157
Liver metastases of colorectal cancer is present in more than 20% of new diagnosed patients and in 40–60% of relapsed patients…
Expand
Highly Cited
1998
Highly Cited
1998
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
M. O’connell
,
D. Nagorney
,
+7 authors
J. Krook
Journal of Clinical Oncology
1998
Corpus ID: 22858567
PURPOSE Extrahepatic metastasis represents a frequent pattern of disease progression when fluorodeoxyuridine (FUDR) is given by…
Expand
Review
1997
Review
1997
Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage.
Karen T. Brown
,
Nancy Kemeny
,
+7 authors
L. Blumgart
Journal of Vascular and Interventional Radiology
1997
Corpus ID: 30217597
1996
1996
Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity.
B. S. Davidson
,
F. Izzo
,
+4 authors
S. Curley
American Journal of Surgery
1996
Corpus ID: 28077643
1992
1992
Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
M. Lorenz
,
C. Hottenrott
,
P. Maier
,
M. Reimann
,
R. Inglis
,
A. Encke
Seminars in Oncology
1992
Corpus ID: 1228986
Hepatic regional treatment represents an attempt to improve tumor response by increasing drug concentration with low systemic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required